![]() ![]() She will also share her recommendations for clinician-scientist trainees. Schrader will talk about her training background, career path and current work. Her clinical genetics specialist training makes her ideally positioned to consider and answer questions regarding the return of incidental genetic information identified throughout the course of massively parallel sequencing projects.įurthermore as co-Medical Director of the BC Cancer agency’s Provincial Hereditary Cancer Program, Dr Schrader is well-positioned to understand the impact of these findings on the public healthcare system. Dr Schrader collaborates on several projects looking at return of this type of information and has the expertise to interpret the clinical significance of incidental findings beyond those primarily associated with cancer. Dr Schrader is an active member of the Personalized OncoGenomics Policy and Ethics working group that has helped to develop a process for return of germline findings from whole genome sequence data generated at the time of tumor sequencing. Her PhD work evolved to include use of next-generation sequencing technology to identify Mendelian disease genes. ![]() Dr Schrader undertook the Royal College of Physicians and Surgeons of Canada Clinician Investigator Program to undertake graduate studies in the Department of Pathology and Laboratory Medicine to investigate the association between germline mutations in CDH1 and lobular breast cancer. Kasmintan Schrader received her medical degree from the University of Melbourne (2003), and completed her residency in Medical Genetics at the University of British Columbia, Canada. Program Medical Co-Director Hereditary Cancerĭr. Kasmintan (Intan) Schrader, MBBS, FRCPC, PhD, DABMG Invited speaker: Andy An, BSc (Pharmacology) and Luke MacLean, MHSc (Clinical Engineering)Ĭurrent UBC MD/PhD students (class of 2025) He will also share his recommendations for clinician-scientist trainees. Dawes will talk about his training background, career path and current work. In addition to his research and practice interests, he has considerable expertise and passion for the development of training programs that allow clinicians to engage in Masters level research. His current research interests include pharmacogenomics in primary care, diabetes prevention, information retrieval, hypertension, and chronic disease management. He was chair of the Program committee of the North American Primary Care Research Group and is currently the Head of the Department of Family Practice at UBC. He was Director of the Centre for Evidence-Based Medicine in Oxford and Head of the Department of Family Medicine at McGill University before coming to UBC in 2010. In 1995 he helped develop a multi-disciplinary Masters programme in Evidence Based Health Care that is run at the University of Oxford. He completed his PhD on weight gain in pregnancy in 1992. Dawes has been a family physician since 1983 working full-time in Oxford for the first 10 years. ![]() Invited speaker: Dr Martin Dawes – MB.BS, MD, DRCOG, FRCGP, CCFPĭepartment of Family Practice | Faculty of Medicine | The University of British Columbiaĭr. All faculty, clinical investigator trainees, and students in the Faculty of Medicine and other members in the UBC community are welcome to join us in person. In addition to speaking about their active research, the invited speakers discuss their experiences and training backgrounds, share their advice with prospective clinician-scientists, and give their opinions on career development options for clinician-scientists. Our seminar series aims to illustrate the relationship that exists between clinical practice and medical research, allowing MD/PhD and other interested students to hear about different career tracks and various ways to combine clinical and research work. MD/PhD “Building Bridges” Seminar Series – ALL ARE WELCOME ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |